A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence
Background and Objective When modelling the pathophysiology of a disease, it is important to select a modelling approach that can adequately replicate its course. The objective of this paper was to compare the outcomes obtained by the Markov and discrete-time microsimulation modelling approaches usi...
Gespeichert in:
Veröffentlicht in: | Clinical drug investigation 2016-11, Vol.36 (11), p.945-956 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 956 |
---|---|
container_issue | 11 |
container_start_page | 945 |
container_title | Clinical drug investigation |
container_volume | 36 |
creator | Laramée, Philippe Millier, Aurélie Brodtkorb, Thor-Henrik Rahhali, Nora Cristeau, Olivier Aballéa, Samuel Montgomery, Stephen Steeves, Sara Toumi, Mondher Rehm, Jürgen |
description | Background and Objective
When modelling the pathophysiology of a disease, it is important to select a modelling approach that can adequately replicate its course. The objective of this paper was to compare the outcomes obtained by the Markov and discrete-time microsimulation modelling approaches using nalmefene clinical trial data.
Methods
Markov and microsimulation modelling approaches assessing alcohol dependence treatment with psychosocial support with or without nalmefene were compared in terms of the modelled evolution of patients’ alcohol consumption and the resulting occurrence of alcohol-attributable harmful events over 1 year.
Results
Comparison of the proportion of the modelled population at different levels of alcohol consumption over time revealed systematic differences arising from the different modelling techniques: a lower number of patients reaching abstinence, a higher number of patients at higher drinking levels, and, overall, a smoother evolution of alcohol consumption in the microsimulation. Reasons are discussed in the paper. While the models produced similar occurrences of alcohol-attributable harmful events as a whole, distinct results for the individual events were observed, explained by the specific pathophysiology of occurrence of these events and how their implementation was adapted to fit the limitations of the compared modelling approaches; however, these differences were only statistically significant for one of the eight events.
Conclusions
For a general public health or health economic assessment of alcohol use disorders, it is possible to achieve similar results with the compared approaches. To assess a patients’ disease course, taking into consideration alcohol-attributable harmful events, the microsimulation approach may provide more precise results. However, further external validation of the models is needed and this additional precision may be outweighed by the greater computational burden of a microsimulation approach. |
doi_str_mv | 10.1007/s40261-016-0442-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01482392v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4305963761</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-9fcb63cac2499ccb907088be66ce6f157a0a88e7612c7035ae25bd601a0d2c7f3</originalsourceid><addsrcrecordid>eNp1kt-O1CAUxhujcf_oA3hjSLzRCxRoC613zezqmMzGRMfrhtLTadcCXaCT-Jo-0dKZcd2YeAX5-H3fOcBJkleUvKeEiA8-I4xTTCjHJMsYFk-Sc0pFiWlJi6eHfYpZztOz5ML7WxJBytnz5IyJTJCMlefJ7wqtrJ6kG7w1yHboRrqfdo-kadHV4JWDAHg7aEA3g3LWD3oeZRgiW02Ts1L14D-i7yfZ7FDoAVV7O7TSKFgCq1HZ3o64CsENzRxkMwJaS6e7eUTXezDBo85Zjb5BO6tD9F9XbM74WU8Heds7O-96tHUgg47Gx-AVTGBaiEVfJM86OXp4eVovkx-frrerNd58_fxlVW2wyggPuOxUw1MlFcvKUqmmJIIURQOcK-AdzYUksihAcMqUIGkugeVNywmVpI1Kl14m7465vRzryQ1aul-1lUO9rjb1ohGaFSwt2Z5G9u2RjW92N4MPtY6PC-MoDdjZ17RgXKR5xhf0zT_orZ2diTeJFCc8LXOWRooeqeVTvIPuoQNK6mU46uNwxCZ4vQxHLaLn9Sl5bjS0D44_0xABdgR8PDI7cI9K_zf1HtPYx8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1860639523</pqid></control><display><type>article</type><title>A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Laramée, Philippe ; Millier, Aurélie ; Brodtkorb, Thor-Henrik ; Rahhali, Nora ; Cristeau, Olivier ; Aballéa, Samuel ; Montgomery, Stephen ; Steeves, Sara ; Toumi, Mondher ; Rehm, Jürgen</creator><creatorcontrib>Laramée, Philippe ; Millier, Aurélie ; Brodtkorb, Thor-Henrik ; Rahhali, Nora ; Cristeau, Olivier ; Aballéa, Samuel ; Montgomery, Stephen ; Steeves, Sara ; Toumi, Mondher ; Rehm, Jürgen</creatorcontrib><description>Background and Objective
When modelling the pathophysiology of a disease, it is important to select a modelling approach that can adequately replicate its course. The objective of this paper was to compare the outcomes obtained by the Markov and discrete-time microsimulation modelling approaches using nalmefene clinical trial data.
Methods
Markov and microsimulation modelling approaches assessing alcohol dependence treatment with psychosocial support with or without nalmefene were compared in terms of the modelled evolution of patients’ alcohol consumption and the resulting occurrence of alcohol-attributable harmful events over 1 year.
Results
Comparison of the proportion of the modelled population at different levels of alcohol consumption over time revealed systematic differences arising from the different modelling techniques: a lower number of patients reaching abstinence, a higher number of patients at higher drinking levels, and, overall, a smoother evolution of alcohol consumption in the microsimulation. Reasons are discussed in the paper. While the models produced similar occurrences of alcohol-attributable harmful events as a whole, distinct results for the individual events were observed, explained by the specific pathophysiology of occurrence of these events and how their implementation was adapted to fit the limitations of the compared modelling approaches; however, these differences were only statistically significant for one of the eight events.
Conclusions
For a general public health or health economic assessment of alcohol use disorders, it is possible to achieve similar results with the compared approaches. To assess a patients’ disease course, taking into consideration alcohol-attributable harmful events, the microsimulation approach may provide more precise results. However, further external validation of the models is needed and this additional precision may be outweighed by the greater computational burden of a microsimulation approach.</description><identifier>ISSN: 1173-2563</identifier><identifier>EISSN: 1179-1918</identifier><identifier>DOI: 10.1007/s40261-016-0442-7</identifier><identifier>PMID: 27470429</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adult ; Alcohol Drinking - drug therapy ; Alcohol-Related Disorders - drug therapy ; Alcoholism - drug therapy ; Economics and Finance ; Female ; Human health and pathology ; Humanities and Social Sciences ; Humans ; Internal Medicine ; Life Sciences ; Medicine ; Medicine & Public Health ; Naltrexone - administration & dosage ; Naltrexone - analogs & derivatives ; Original Research Article ; Pharmacology/Toxicology ; Pharmacotherapy ; Psychiatrics and mental health ; Psychology ; Santé publique et épidémiologie</subject><ispartof>Clinical drug investigation, 2016-11, Vol.36 (11), p.945-956</ispartof><rights>Springer International Publishing Switzerland 2016</rights><rights>Copyright Springer Science & Business Media Nov 2016</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-9fcb63cac2499ccb907088be66ce6f157a0a88e7612c7035ae25bd601a0d2c7f3</citedby><cites>FETCH-LOGICAL-c406t-9fcb63cac2499ccb907088be66ce6f157a0a88e7612c7035ae25bd601a0d2c7f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40261-016-0442-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40261-016-0442-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27470429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01482392$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Laramée, Philippe</creatorcontrib><creatorcontrib>Millier, Aurélie</creatorcontrib><creatorcontrib>Brodtkorb, Thor-Henrik</creatorcontrib><creatorcontrib>Rahhali, Nora</creatorcontrib><creatorcontrib>Cristeau, Olivier</creatorcontrib><creatorcontrib>Aballéa, Samuel</creatorcontrib><creatorcontrib>Montgomery, Stephen</creatorcontrib><creatorcontrib>Steeves, Sara</creatorcontrib><creatorcontrib>Toumi, Mondher</creatorcontrib><creatorcontrib>Rehm, Jürgen</creatorcontrib><title>A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence</title><title>Clinical drug investigation</title><addtitle>Clin Drug Investig</addtitle><addtitle>Clin Drug Investig</addtitle><description>Background and Objective
When modelling the pathophysiology of a disease, it is important to select a modelling approach that can adequately replicate its course. The objective of this paper was to compare the outcomes obtained by the Markov and discrete-time microsimulation modelling approaches using nalmefene clinical trial data.
Methods
Markov and microsimulation modelling approaches assessing alcohol dependence treatment with psychosocial support with or without nalmefene were compared in terms of the modelled evolution of patients’ alcohol consumption and the resulting occurrence of alcohol-attributable harmful events over 1 year.
Results
Comparison of the proportion of the modelled population at different levels of alcohol consumption over time revealed systematic differences arising from the different modelling techniques: a lower number of patients reaching abstinence, a higher number of patients at higher drinking levels, and, overall, a smoother evolution of alcohol consumption in the microsimulation. Reasons are discussed in the paper. While the models produced similar occurrences of alcohol-attributable harmful events as a whole, distinct results for the individual events were observed, explained by the specific pathophysiology of occurrence of these events and how their implementation was adapted to fit the limitations of the compared modelling approaches; however, these differences were only statistically significant for one of the eight events.
Conclusions
For a general public health or health economic assessment of alcohol use disorders, it is possible to achieve similar results with the compared approaches. To assess a patients’ disease course, taking into consideration alcohol-attributable harmful events, the microsimulation approach may provide more precise results. However, further external validation of the models is needed and this additional precision may be outweighed by the greater computational burden of a microsimulation approach.</description><subject>Adult</subject><subject>Alcohol Drinking - drug therapy</subject><subject>Alcohol-Related Disorders - drug therapy</subject><subject>Alcoholism - drug therapy</subject><subject>Economics and Finance</subject><subject>Female</subject><subject>Human health and pathology</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Life Sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Naltrexone - administration & dosage</subject><subject>Naltrexone - analogs & derivatives</subject><subject>Original Research Article</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Psychiatrics and mental health</subject><subject>Psychology</subject><subject>Santé publique et épidémiologie</subject><issn>1173-2563</issn><issn>1179-1918</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kt-O1CAUxhujcf_oA3hjSLzRCxRoC613zezqmMzGRMfrhtLTadcCXaCT-Jo-0dKZcd2YeAX5-H3fOcBJkleUvKeEiA8-I4xTTCjHJMsYFk-Sc0pFiWlJi6eHfYpZztOz5ML7WxJBytnz5IyJTJCMlefJ7wqtrJ6kG7w1yHboRrqfdo-kadHV4JWDAHg7aEA3g3LWD3oeZRgiW02Ts1L14D-i7yfZ7FDoAVV7O7TSKFgCq1HZ3o64CsENzRxkMwJaS6e7eUTXezDBo85Zjb5BO6tD9F9XbM74WU8Heds7O-96tHUgg47Gx-AVTGBaiEVfJM86OXp4eVovkx-frrerNd58_fxlVW2wyggPuOxUw1MlFcvKUqmmJIIURQOcK-AdzYUksihAcMqUIGkugeVNywmVpI1Kl14m7465vRzryQ1aul-1lUO9rjb1ohGaFSwt2Z5G9u2RjW92N4MPtY6PC-MoDdjZ17RgXKR5xhf0zT_orZ2diTeJFCc8LXOWRooeqeVTvIPuoQNK6mU46uNwxCZ4vQxHLaLn9Sl5bjS0D44_0xABdgR8PDI7cI9K_zf1HtPYx8A</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Laramée, Philippe</creator><creator>Millier, Aurélie</creator><creator>Brodtkorb, Thor-Henrik</creator><creator>Rahhali, Nora</creator><creator>Cristeau, Olivier</creator><creator>Aballéa, Samuel</creator><creator>Montgomery, Stephen</creator><creator>Steeves, Sara</creator><creator>Toumi, Mondher</creator><creator>Rehm, Jürgen</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><scope>BXJBU</scope></search><sort><creationdate>20161101</creationdate><title>A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence</title><author>Laramée, Philippe ; Millier, Aurélie ; Brodtkorb, Thor-Henrik ; Rahhali, Nora ; Cristeau, Olivier ; Aballéa, Samuel ; Montgomery, Stephen ; Steeves, Sara ; Toumi, Mondher ; Rehm, Jürgen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-9fcb63cac2499ccb907088be66ce6f157a0a88e7612c7035ae25bd601a0d2c7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Alcohol Drinking - drug therapy</topic><topic>Alcohol-Related Disorders - drug therapy</topic><topic>Alcoholism - drug therapy</topic><topic>Economics and Finance</topic><topic>Female</topic><topic>Human health and pathology</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Life Sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Naltrexone - administration & dosage</topic><topic>Naltrexone - analogs & derivatives</topic><topic>Original Research Article</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Psychiatrics and mental health</topic><topic>Psychology</topic><topic>Santé publique et épidémiologie</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laramée, Philippe</creatorcontrib><creatorcontrib>Millier, Aurélie</creatorcontrib><creatorcontrib>Brodtkorb, Thor-Henrik</creatorcontrib><creatorcontrib>Rahhali, Nora</creatorcontrib><creatorcontrib>Cristeau, Olivier</creatorcontrib><creatorcontrib>Aballéa, Samuel</creatorcontrib><creatorcontrib>Montgomery, Stephen</creatorcontrib><creatorcontrib>Steeves, Sara</creatorcontrib><creatorcontrib>Toumi, Mondher</creatorcontrib><creatorcontrib>Rehm, Jürgen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>HAL-SHS: Archive ouverte en Sciences de l'Homme et de la Société</collection><jtitle>Clinical drug investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laramée, Philippe</au><au>Millier, Aurélie</au><au>Brodtkorb, Thor-Henrik</au><au>Rahhali, Nora</au><au>Cristeau, Olivier</au><au>Aballéa, Samuel</au><au>Montgomery, Stephen</au><au>Steeves, Sara</au><au>Toumi, Mondher</au><au>Rehm, Jürgen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence</atitle><jtitle>Clinical drug investigation</jtitle><stitle>Clin Drug Investig</stitle><addtitle>Clin Drug Investig</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>36</volume><issue>11</issue><spage>945</spage><epage>956</epage><pages>945-956</pages><issn>1173-2563</issn><eissn>1179-1918</eissn><abstract>Background and Objective
When modelling the pathophysiology of a disease, it is important to select a modelling approach that can adequately replicate its course. The objective of this paper was to compare the outcomes obtained by the Markov and discrete-time microsimulation modelling approaches using nalmefene clinical trial data.
Methods
Markov and microsimulation modelling approaches assessing alcohol dependence treatment with psychosocial support with or without nalmefene were compared in terms of the modelled evolution of patients’ alcohol consumption and the resulting occurrence of alcohol-attributable harmful events over 1 year.
Results
Comparison of the proportion of the modelled population at different levels of alcohol consumption over time revealed systematic differences arising from the different modelling techniques: a lower number of patients reaching abstinence, a higher number of patients at higher drinking levels, and, overall, a smoother evolution of alcohol consumption in the microsimulation. Reasons are discussed in the paper. While the models produced similar occurrences of alcohol-attributable harmful events as a whole, distinct results for the individual events were observed, explained by the specific pathophysiology of occurrence of these events and how their implementation was adapted to fit the limitations of the compared modelling approaches; however, these differences were only statistically significant for one of the eight events.
Conclusions
For a general public health or health economic assessment of alcohol use disorders, it is possible to achieve similar results with the compared approaches. To assess a patients’ disease course, taking into consideration alcohol-attributable harmful events, the microsimulation approach may provide more precise results. However, further external validation of the models is needed and this additional precision may be outweighed by the greater computational burden of a microsimulation approach.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>27470429</pmid><doi>10.1007/s40261-016-0442-7</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1173-2563 |
ispartof | Clinical drug investigation, 2016-11, Vol.36 (11), p.945-956 |
issn | 1173-2563 1179-1918 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_01482392v1 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adult Alcohol Drinking - drug therapy Alcohol-Related Disorders - drug therapy Alcoholism - drug therapy Economics and Finance Female Human health and pathology Humanities and Social Sciences Humans Internal Medicine Life Sciences Medicine Medicine & Public Health Naltrexone - administration & dosage Naltrexone - analogs & derivatives Original Research Article Pharmacology/Toxicology Pharmacotherapy Psychiatrics and mental health Psychology Santé publique et épidémiologie |
title | A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A38%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Comparison%20of%20Markov%20and%20Discrete-Time%20Microsimulation%20Approaches:%20Simulating%20the%20Avoidance%20of%20Alcohol-Attributable%20Harmful%20Events%20from%20Reduction%20of%20Alcohol%20Consumption%20Through%20Treatment%20of%20Alcohol%20Dependence&rft.jtitle=Clinical%20drug%20investigation&rft.au=Laram%C3%A9e,%20Philippe&rft.date=2016-11-01&rft.volume=36&rft.issue=11&rft.spage=945&rft.epage=956&rft.pages=945-956&rft.issn=1173-2563&rft.eissn=1179-1918&rft_id=info:doi/10.1007/s40261-016-0442-7&rft_dat=%3Cproquest_hal_p%3E4305963761%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1860639523&rft_id=info:pmid/27470429&rfr_iscdi=true |